Go Pro
LON:EBQ

Ebiquity (EBQ) Share Price, News & Analysis

Ebiquity logo
GBX 9.62 0.00 (0.00%)
As of 07/21/2026

About Ebiquity Stock (LON:EBQ)

Advanced

Key Stats

Today's Range
9.63
9.75
50-Day Range
9.60
11.07
52-Week Range
9.60
23.50
Volume
228 shs
Average Volume
151,914 shs
Market Capitalization
£13.37 million
P/E Ratio
N/A
Dividend Yield
2.33%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EBQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ebiquity and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EBQ Stock News Headlines

NNVC: FDA = New Momentum Wave!
NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for its antiviral NV-387, targeting measles — a disease with no approved antiviral treatment currently on the market. NV-387 is designed as a broad-spectrum antiviral with potential applications across RSV, influenza, coronaviruses, Mpox, and more. With Phase II trials advancing and measles cases resurging globally, NNVC is entering a notable inflection point.tc pixel
See More Headlines

EBQ Stock Analysis - Frequently Asked Questions

Ebiquity's stock was trading at GBX 12.51 at the start of the year. Since then, EBQ stock has decreased by 23.1% and is now trading at GBX 9.63.

Ebiquity plc (LON:EBQ) released its earnings results on Tuesday, April, 21st. The company reported ($1.39) EPS for the quarter. The company had revenue of $73.36 million for the quarter. Ebiquity had a negative trailing twelve-month return on equity of 55.27% and a negative net margin of 19.11%.

Shares of EBQ stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ebiquity investors own include B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR), Greencore Group (GNC), Intel (INTC) and IQE (IQE).

Company Calendar

Last Earnings
4/21/2026
Today
7/22/2026

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Advertising Agencies
Sub-Industry
N/A
Current Symbol
LON:EBQ
CIK
N/A
Fax
N/A
Employees
652
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (10.14)
Trailing P/E Ratio
N/A
Forward P/E Ratio
3.30
P/E Growth
0.75
Net Income
-£5.68 million
Net Margins
-19.11%
Pretax Margin
N/A
Return on Equity
-55.27%
Return on Assets
1.64%

Debt

Debt-to-Equity Ratio
107.50
Current Ratio
1.78
Quick Ratio
1.23

Sales & Book Value

Annual Sales
£73.36 million
Price / Sales
0.18
Cash Flow
GBX 2.10 per share
Price / Cash Flow
4.58
Book Value
GBX 29.39 per share
Price / Book
0.33

Miscellaneous

Outstanding Shares
138,953,000
Free Float
N/A
Market Cap
£13.37 million
Optionable
Not Optionable
Beta
0.21
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (LON:EBQ) was last updated on 7/22/2026 by MarketBeat.com Staff.
From Our Partners